Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIqgeo Regulatory News (IQG)

Share Price Information for Iqgeo (IQG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 467.00
Bid: 462.00
Ask: 472.00
Change: 0.00 (0.00%)
Spread: 10.00 (2.165%)
Open: 467.00
High: 467.00
Low: 467.00
Prev. Close: 467.00
IQG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors' Dealings

22 Jun 2017 10:51

RNS Number : 8776I
Ubisense Group PLC
22 June 2017
 

22 June 2017

 

Ubisense Group Plc

Directors' Dealings

Ubisense Group plc (LSE:UBI, "Company" or "Ubisense") received notification on 21 June 2017 from Kestrel Partners LLP ("Kestrel") that on 21 June 2017 it acquired, on behalf of its discretionary clients, 115,000 ordinary shares of 2p each ("Shares") in the Company at a price of £0.37 per share. The notification also included the matters set out below.

Kestrel is the investment manager to Kestrel Opportunities, a cell of Guernsey Portfolios PCC Limited ("Kestrel Opportunities"), and various other clients. This disclosure relates to indirect Shares and voting rights in the Company that are managed by Kestrel on a discretionary basis.

Mr Scott is a partner of, and holds a beneficial interest in Kestrel. Mr Scott is also a shareholder in Kestrel Opportunities and is therefore deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding in Ubisense.

Prior to this purchase of Shares, Kestrel on a combined basis indirectly held Shares and voting rights over 15,915,493 Shares in the Company.

Of the Shares purchased, 97,750 were acquired on behalf of Kestrel Opportunities and following this transaction, Kestrel Opportunities holds (and consequently Mr Scott is deemed to have a beneficial interest in) 11,855,785 Shares in the Company. The remaining 17,250 Shares were purchased on behalf of Kestrel's other discretionary clients, in which Mr Scott has no beneficial interest, who, following this transaction, hold a further 4,174,708 Shares in the Company.

Following this transaction and on a combined basis, Kestrel indirectly holds voting rights over 16,030,493 Shares in the Company, which represents approximately 28.69% per cent of the Company's issued share capital.

Kestrel's interest in the Shares in the Company is held through the following nominees:

 

Holding type

Nominee

No. of shares

% of issued share capital

Indirect

Bank of New York Nominees Ltd

11,855,785

21.22%

Indirect

JIM Nominees Limited

1,306,095

2.34%

Indirect

Bank of New York Nominees Ltd

2,868,613

5.13%

 

For further information contact:

 

Ubisense Group PLCPeter Harverson

Tim Gingell

 

+44 (0) 1223 535 170

Numis Securities LimitedSimon Willis

Jamie Lillywhite

Toby Adcock

+44 (0) 20 7260 1000

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHKMGZVLZGGNZG
Date   Source Headline
20th Nov 20182:00 pmRNSPrice Monitoring Extension
6th Nov 20184:28 pmRNSHolding(s) in Company
27th Sep 20187:00 amRNSHalf-year Report
30th Aug 20187:00 amRNSStrategy/Company/Ops Update
7th Aug 20187:00 amRNSTrading Update
2nd Jul 20187:00 amRNSBlock listing Return
19th Jun 20189:05 amRNSSecond Price Monitoring Extn
19th Jun 20189:00 amRNSPrice Monitoring Extension
19th Jun 20187:00 amRNSMajor SmartSpace contract for military training
30th May 20182:09 pmRNSHolding(s) in Company
26th Apr 201811:16 amRNSResult of AGM
16th Apr 20183:50 pmRNSDirector/PDMR Shareholding
3rd Apr 20187:00 amRNSPosting of Annual Report and notice of AGM
28th Mar 20187:00 amRNSChange of Nominated Adviser
19th Mar 20187:33 amRNSHolding(s) in Company
15th Mar 20187:00 amRNSUbisense Group plc Annual Report 2017
6th Mar 20187:00 amRNSUbisense Japan update
24th Jan 20187:00 amRNSTrading Statement
2nd Jan 20187:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
13th Dec 20177:00 amRNSFirst win in space and satellites sector
1st Dec 20177:00 amRNSTotal Voting Rights
13th Nov 20174:03 pmRNSTR-1: Notification of major holdings
8th Nov 20174:18 pmRNSTR-1: Notification of major holdings
3rd Nov 20172:15 pmRNSResult of General Meeting
18th Oct 20177:00 amRNSSignificant contract extension
18th Oct 20177:00 amRNSPlacing Announcement
28th Sep 20177:00 amRNSInterim Results
13th Sep 20177:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
11th Sep 20173:16 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
1st Aug 20177:00 amRNSTrading Update
3rd Jul 20177:00 amRNSBlock listing Interim Review
3rd Jul 20177:00 amRNSTotal Voting Rights
30th Jun 20175:17 pmRNSDirectors' Dealings
22nd Jun 201710:51 amRNSDirectors' Dealings
16th May 20172:31 pmRNSResult of AGM
7th Apr 20177:00 amRNSPosting of Annual Report and Notice of AGM
31st Mar 20174:14 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
29th Mar 20177:00 amRNSDirectors' Dealings
27th Mar 20177:00 amRNSDirectors' Dealings
22nd Mar 20177:00 amRNSDirectors' Dealings
21st Mar 20177:00 amRNSFinal Results
16th Mar 20177:00 amRNSNotice of Results
1st Mar 20172:39 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
27th Feb 20175:07 pmRNSTR-1: Notifications of Major Interests in Shares
8th Feb 20177:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
27th Jan 20177:00 amRNSTrading Statement
3rd Jan 20177:00 amRNSBlock listing Interim Review
15th Dec 20167:00 amRNSAppointment of CEO
15th Dec 20167:00 amRNSDirectors Dealings
25th Nov 20165:37 pmRNSDirectors' Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.